
Brazil's largest cancer-care group, Oncoclínicas, saw its Q2 2026 net loss more than triple to R$475.7 million (about US$91 million) as revenue fell and drug shortages hit its clinics. The post Oncoclínicas Q2 Loss More Than Triples to…
View original source — Rio Times ↗



